Studies involving disease:COVID-19

Study ID Study Title Species Institute
ST001709SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibitionHumanUniversity of California, Los Angeles
ST001735The COVIDome Explorer Researcher Portal (Red Blood Cells)HumanUniversity of Colorado Anschutz Medical Campus
ST001736The COVIDome Explorer Researcher Portal (blood plasma)HumanUniversity of Colorado Anschutz Medical Campus
ST001849Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I)HumanWashington University in St. Louis
ST001853Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (Part 2)HamsterWashington University in St. Louis
ST001921An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 InfectionHumanWeill Cornell Medicine
ST001933Absolute quantification of plasma cytokines and metabolome reveals the glycylproline regulating antibody-fading in convalescent COVID-19 patientsHumanHong Kong Baptist University
ST001993CE-MS based metabolomics to study plasma samples that reveal new pathways implicated in SARS-CoV-2 pathogenesisHumanUniversidad CEU San Pablo
ST002016Metabolomics of COVID patientsHumanUniversity of Virginia
ST002086Serum NMR profiling reveals differential alterations in the lipoproteome induced by Pfizer-BioNTech vaccine in COVID-19–recovered subjects and naïve subjectsHumanUniversity of Florence
ST002087Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patientsHumanUniversity of Florence
ST002194Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulationHumanCEMBIO
ST002291Integrated metabolic and inflammatory signatures associated with severity, fatality, and recovery of COVID-19HumanFederal University of Goiás

Return to search page